Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of “Moderate Buy” from Analysts
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective […]
More Stories
Treasury Secretary Says Fed Will Likely Take Its Time to Reduce Balance Sheet
By Jacob Burg Treasury Secretary Scott Bessent said on Feb. 8 that he doesn’t expect the Federal Reserve to quickly...
US, Argentina Finalize Trade Agreement
By Bill Pan The United States and Argentina have finalized a new trade deal under which two of the Western...
Lindsey Vonn Breaks Leg in Downhill Crash at Winter Olympics, in Stable Condition After Surgery
By The Associated Press CORTINA D’AMPEZZO, Italy—Lindsey Vonn ’s defiant bid to win the Winter Olympic downhill at the age...
Shadows of Scandal: The Guthrie Kidnapping and the Clinton-Epstein Nexus
By Stephen Zogopoulos, USNN World News In the swirling vortex of American politics, where power, secrecy, and scandal often intersect,...
Takaichi’s Ruling Bloc Wins Landslide Election in Japan’s Lower House
By Jacob Burg Japanese Prime Minister Sanae Takaichi’s ruling coalition swept to a single-party majority victory in a critical parliamentary...
Ohio Man Charged Over Alleged Threat to Kill JD Vance
By Bill Pan An Ohio man has been charged with threatening to kill Vice President JD Vance when the Republican...